Rtw Investments 13F: Adds $47M to Intuitive Surgical (ISRG) Stake

RTW Investments has significantly increased its stake in Intuitive Surgical, Inc. (NasdaqGS: ISRG), as revealed in its latest 13F filing with the Securities and Exchange Commission. The fund added 118,772 shares, growing its holdings by 117% to a total of 220,000 shares, valued at approximately $90.4 million as of the reporting period.

What Changed in RTW Investments' Intuitive Surgical Position

RTW Investments' decision to boost its stake in Intuitive Surgical by 117% indicates a strong vote of confidence in the medical technology company. Before this move, the fund held 101,228 shares and now possesses 220,000 shares. This significant increase reflects a strategic investment decision by RTW Investments.

Other Institutional Activity in Intuitive Surgical

Among other institutional investors, BlackRock, Inc. trimmed its holdings by 440,248 shares, leaving it with 30,075,905 shares valued at about $13.9 billion. Vanguard Capital Management LLC maintained its position with 23,079,490 shares worth approximately $10.6 billion. State Street Corp added 145,382 shares, ending with 15,846,973 shares valued at $7.3 billion. Geode Capital Management, LLC increased its stake by 241,160 shares to 8,466,851 shares, valued at $3.9 billion.

Intuitive Surgical, Inc. Stock Down 5.4%

Shares of Intuitive Surgical, Inc. (NasdaqGS: ISRG) traded at around $411.06 recently. The company boasts a market cap of approximately $145.6 billion and has a P/E ratio of 50.01. Its forward P/E stands at 34.88, and it has a beta of 1.453. The stock's 52-week range is between $396.68 and $603.88, with a 50-day moving average of $443.28 and a 200-day moving average of $491.91.

Recent Earnings

Intuitive Surgical reported revenues of $10.6 billion, reflecting a growth rate of 23%. The company achieved an EPS of $8.22, with a net margin of 28.15% and a return on equity of 17.23%. The next earnings report is anticipated on April 21, 2026.

Insider Buying and Selling at Intuitive Surgical, Inc.

Recent insider transactions include EVP & Chief Manufacturing and Supply Chain Officer Mark Brosius selling 25 shares on June 12, 2026, and 23 shares on June 11, 2026, at prices of $414.13 and $412.16, respectively, under planned sales. EVP & Chief Legal and Compliance Officer Gary Loeb sold 400 shares at $424.14 on June 10, 2026. CEO David Rosa sold 1,358 shares on the same day without a price listed, and also bought 1,358 shares, indicating a planned transaction.

Analysts Set New Price Targets

Analysts remain optimistic about Intuitive Surgical. On May 18, 2026, B of A Securities maintained its 'buy' rating with a $520 price target. Barclays, on April 23, 2026, also maintained a 'buy' rating with a target of $651. The consensus among analysts is a 'buy' recommendation, with an average target price of $565.08 based on 29 opinions.

About Intuitive Surgical

Intuitive Surgical, Inc., headquartered in Sunnyvale, California, develops and markets products that enhance minimally invasive care. Known for its da Vinci Surgical System, the company provides advanced tools for surgical procedures and diagnostic endoluminal procedures. Led by CEO David J. Rosa, Intuitive Surgical employs over 17,000 people and serves healthcare providers worldwide.

Bottom Line

RTW Investments' substantial increase in its Intuitive Surgical stake underscores a strong belief in the company's potential. As a leader in minimally invasive surgical technology, Intuitive Surgical continues to attract attention from institutional investors. However, it's important to remember that 13F filings are backward-looking and may not represent current positions.